Immunotherapy: Keeping breast cancer in check

Nature Reviews Cancer 17, 454 (2017). doi:10.1038/nrc.2017.55 Author: Liesbet Lieben Nolan et al. show that triple-negative breast cancers with BRCA1 mutations are immunogenic and susceptible to treatment with a combination of two checkpoint inhibitors and chemotherapy.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Research Highlight Source Type: research